CompletedNot Applicable

Intraventricular Stasis in Non Ischemic Dilated Myocardiopathy

Spain80 participantsStarted 2018-02-10

Plain-language summary

This study is designed to quantify the ventricular stasis in patients with non-ischemic dilated cardiomyopathy by post-processing of 2D color Doppler echocardiography images in order to establish the relationship between quantitative variables of intraventricular stasis and the prevalence of silent embolic events and/or intraventricular mural thrombosis determined by magnetic resonance.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of nonischemic dilated cardiomyopathy. * Sinus rhythm. * LV ejection fraction (EF) less than 45%. * Signature of informed consent for the study. Exclusion Criteria: * Implantable defibrillation or stimulation devices not compatible with MRI. * Hemodynamically significant primary valvular disease or cardiac valve prosthesis. * Claustrophobia. * Documented history of paroxysmal or persistent atrial fibrillation (AF). * Previous carotid disease diagnosed with stenosis greater than 50%. * Complete oral anticoagulation prior to inclusion in the study or indication of anticoagulation. * Known prothrombotic states (active oncological pathology, alteration of the coagulation cascade).

What they're measuring

Prevalence of the combined binary variable consisting of left ventricular mural thrombosis or silent brain infarct detected by magnetic resonance imaging

Timeframe: Within 10 days after enrollment

Trial details

NCT IDNCT03415789

SponsorHospital General Universitario Gregorio Marañon

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-11-23

View on ClinicalTrials.gov More Dilated Cardiomyopathy trials